These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19389440)

  • 1. Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector.
    Miller JP; Geng Y; Ng HL; Yang OO; Krogstad P
    Vaccine; 2009 Jun; 27(30):3992-4000. PubMed ID: 19389440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.
    Lorin C; Vanloubbeeck Y; Baudart S; Ska M; Bayat B; Brauers G; Clarinval G; Donner MN; Marchand M; Koutsoukos M; Mettens P; Cohen J; Voss G
    PLoS One; 2015; 10(4):e0122835. PubMed ID: 25856308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
    Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
    J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.
    Khattar SK; Manoharan V; Bhattarai B; LaBranche CC; Montefiori DC; Samal SK
    mBio; 2015 Jul; 6(4):e01005. PubMed ID: 26199332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
    J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the CpG dinucleotide abundance in the HIV-1 genomic RNA inhibits viral replication.
    Antzin-Anduetza I; Mahiet C; Granger LA; Odendall C; Swanson CM
    Retrovirology; 2017 Nov; 14(1):49. PubMed ID: 29121951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
    McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
    J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses.
    Carnero E; Li W; Borderia AV; Moltedo B; Moran T; García-Sastre A
    J Virol; 2009 Jan; 83(2):584-97. PubMed ID: 19004953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a foreign peptide expressed within a capsid protein of an attenuated coxsackievirus.
    Halim SS; Ostrowski SE; Lee WT; Ramsingh AI
    Vaccine; 2000 Nov; 19(7-8):958-65. PubMed ID: 11115722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.
    Cooper D; Wright KJ; Calderon PC; Guo M; Nasar F; Johnson JE; Coleman JW; Lee M; Kotash C; Yurgelonis I; Natuk RJ; Hendry RM; Udem SA; Clarke DK
    J Virol; 2008 Jan; 82(1):207-19. PubMed ID: 17942549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.
    Qiu JT; Liu B; Tian C; Pavlakis GN; Yu XF
    J Virol; 2000 Jul; 74(13):5997-6005. PubMed ID: 10846081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Rhinovirus-A1 as an Expression Vector.
    Tomusange K; Wijesundara D; Gowans EJ; Grubor-Bauk B
    Methods Mol Biol; 2017; 1581():181-201. PubMed ID: 28374250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
    Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
    J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients.
    Sakkhachornphop S; Hadpech S; Wisitponchai T; Panto C; Kantamala D; Utaipat U; Praparattanapan J; Kotarathitithum W; Taejaroenkul S; Yasamut U; Chupradit K; Moonmuang S; Sanghiran Lee V; Suparatpinyo K; Tayapiwatana C
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30428529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
    Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
    Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
    Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
    J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.